Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-026536
Date:2021-06-25
Issuer: T2 BIOSYSTEMS, INC. (TTOO)
Original Submission Date:

Reporting Person:

CUMMING JOHN W
101 HARTWELL AVE
LEXINGTON, MA 02421

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-25 M 45,454 a $0.00 69,034 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2021-06-25 deemed execution date M 45,454 (d) common stock 45,454 $0.00 45,454 direct
RESTRICTED STOCK UNITS 0.0 2021-06-25 deemed execution date A 81,967 (a) common stock 81,967 $0.00 81,967 direct
Footnotes
IDfootnote
f1 each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
f2 on august 6, 2020 the reporting person was granted 45,454 restricted stock units that vested on june 25, 2021.
f3 the restricted stock units vest in one installment on the earlier of (i) june 25, 2022 and (ii) the date of the next annual meeting of stockholders.
WhaleWisdom Logo

Elevate your investments